SLC1A5 and lung carcinoma: Lung cancer cells exhibit a marked dependence on glutamine, facilitated by upregulation of transporters such as alanine, serine, cysteine transporter 2 (ASCT2/SLC1A5) and enhanced glutaminase activity to drive uptake and catabolism [32].